Glecaprevir + pibrentasvir (Maviret)
- BNF:
- Not listed
- Status:
- Red
- Decision Date:
- February 2018
Comments
RED1,2,3: NICE TA499: Treatment of chronic hepatitis C virus infections in adults. (Decision date - February 2018)
NHS England drug - to be used in line with NHS England commissioning intentions
Red Drug Classifications
- 5: Is new to clinical practice and unfamiliar, necessitating a period of accumulation of experience, firstly (and most rapidly) by consultants/specialists
search again